JMP Securities Reiterates Market Outperform on Steris, Maintains $265 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on Steris (NYSE:STE) and maintained a price target of $265.
August 07, 2024 | 8:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on Steris and maintained a price target of $265.
The reiteration of a Market Outperform rating and a maintained price target of $265 by JMP Securities is a positive signal for investors, likely boosting short-term confidence and stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100